Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos H Barcenas

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Clinical Breast Cancer|September 21, 2023
Bone-Targeted Therapy Regimen and Skeletal-Related Events in Patients Surviving Longer Than 2 Years With Metastatic Breast Cancer and Bone MetastasisAthira Jayan, Akshara Singareeka Raghavendra, Roland Bassett, et al.
Clinical Breast Cancer|December 15, 2017
Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer SurvivorsAkshara Raghavendra, Arup K Sinha, Janeiro Valle-Goffin, et al.
JCO Oncology Practice|April 28, 2026
Chemotherapy Declination Among Patients With Early-Stage Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer and High Oncotype DX Recurrence ScoresInimfon Jackson, Xiudong Lei, Marija Sullivan, et al.
Clinical Breast Cancer|February 6, 2010
Race as an independent risk factor for breast cancer survival: breast cancer outcomes from the medical college of georgia tumor registryCarlos H Barcenas, Jeremy Wells, Daniel Chong, et al.
CA: a Cancer Journal for Clinicians|January 12, 2026
Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancerAkshara Singareeka Raghavendra, Senthil Damodaran, Carlos H Barcenas, et al.
Plastic and Reconstructive Surgery|August 28, 2025
The Impact of Vascularized Lymph Node Transfer in Reducing the Rate of Cellulitis in Patients with Breast Cancer-Related LymphedemaAlejandro Perez, Mark V Schaverien, Monica George-Palop, et al.
JAMA Network Open|April 28, 2025
Clinical Characteristics and Survival Outcomes of Metastatic Invasive Lobular and Ductal CarcinomaAkshara S Raghavendra, Roland Bassett, Senthil Damodaran, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|September 23, 2025
Feasibility, acceptability, and experienced benefits of kind acts and gratitude letter interventions among collectivist and individualist culture cancer patients and caregivers: A pilot studyLilian J Shin-Cho, Meagan Whisenant, Lorenzo Cohen, et al.
The Oncologist|February 29, 2012
Anthracycline regimen adherence in older patients with early breast cancerCarlos H Barcenas, Ning Zhang, Hui Zhao, et al.
American Journal of Industrial Medicine|March 19, 2005
Wood dust exposure and the association with lung cancer riskCarlos H Barcenas, George L Delclos, Randa El-Zein, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Clinical Breast Cancer|September 21, 2023
Bone-Targeted Therapy Regimen and Skeletal-Related Events in Patients Surviving Longer Than 2 Years With Metastatic Breast Cancer and Bone MetastasisAthira Jayan, Akshara Singareeka Raghavendra, Roland Bassett, et al.
Clinical Breast Cancer|December 15, 2017
Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer SurvivorsAkshara Raghavendra, Arup K Sinha, Janeiro Valle-Goffin, et al.
JCO Oncology Practice|April 28, 2026
Chemotherapy Declination Among Patients With Early-Stage Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer and High Oncotype DX Recurrence ScoresInimfon Jackson, Xiudong Lei, Marija Sullivan, et al.
Clinical Breast Cancer|February 6, 2010
Race as an independent risk factor for breast cancer survival: breast cancer outcomes from the medical college of georgia tumor registryCarlos H Barcenas, Jeremy Wells, Daniel Chong, et al.
CA: a Cancer Journal for Clinicians|January 12, 2026
Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancerAkshara Singareeka Raghavendra, Senthil Damodaran, Carlos H Barcenas, et al.
Plastic and Reconstructive Surgery|August 28, 2025
The Impact of Vascularized Lymph Node Transfer in Reducing the Rate of Cellulitis in Patients with Breast Cancer-Related LymphedemaAlejandro Perez, Mark V Schaverien, Monica George-Palop, et al.
JAMA Network Open|April 28, 2025
Clinical Characteristics and Survival Outcomes of Metastatic Invasive Lobular and Ductal CarcinomaAkshara S Raghavendra, Roland Bassett, Senthil Damodaran, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|September 23, 2025
Feasibility, acceptability, and experienced benefits of kind acts and gratitude letter interventions among collectivist and individualist culture cancer patients and caregivers: A pilot studyLilian J Shin-Cho, Meagan Whisenant, Lorenzo Cohen, et al.
The Oncologist|February 29, 2012
Anthracycline regimen adherence in older patients with early breast cancerCarlos H Barcenas, Ning Zhang, Hui Zhao, et al.
American Journal of Industrial Medicine|March 19, 2005
Wood dust exposure and the association with lung cancer riskCarlos H Barcenas, George L Delclos, Randa El-Zein, et al.
Pageof 8